Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multimodality approaches for pancreatic cancer.

Literature DB >> 16282280

Multimodality approaches for pancreatic cancer.

Gary Y Yang¹, Timothy D Wagner, Martin Fuss, Charles R Thomas.

Abstract

The role of combined-modality therapy for pancreatic cancer is evolving with the recent development and completion of major, multi-institutional clinical trials. One of the challenges for the busy clinician is to appreciate the variation in staging, surgical expertise, and application of either definitive chemoradiotherapy or adjuvant chemoradiotherapy for local and/or regionally advanced disease. Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer.

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16282280 DOI： 10.3322/canjclin.55.6.352

Source DB: PubMed Journal: CA Cancer J Clin ISSN： 0007-9235 Impact factor: 508.702

Keyword Cloud
Cited

14 in total

1. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.

Authors: Deniz A Ucar; Andrew T Magis; Di-Hua He; Nicholas J Lawrence; Said M Sebti; Elena Kurenova; Maria Zajac-Kaye; Jianliang Zhang; Steven N Hochwald
Journal: Anticancer Agents Med Chem Date: 2013-05 Impact factor: 2.505

2. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine.

Authors: Huaqiang Ouyang; Peng Wang; Zhiqiang Meng; Zhen Chen; Er'xin Yu; Huan Jin; David Z Chang; Zhongxing Liao; Lorenzo Cohen; Luming Liu
Journal: Pancreas Date: 2011-01 Impact factor: 3.327

Review 3. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.

Authors: Vicki L Keedy; Jordan Berlin
Journal: Curr Treat Options Oncol Date: 2006-09

4. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer.

Authors: Gary Y Yang; Nadia K Malik; Rameela Chandrasekhar; Wen-Wee Ma; Leayn Flaherty; Renuka Iyer; Boris Kuvshinoff; John Gibbs; Gregory Wilding; Graham Warren; Kilian Salerno May
Journal: J Gastrointest Oncol Date: 2013-12

5. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.

Authors: Nadia K Malik; Kilian Salerno May; Rameela Chandrasekhar; Wen Wee; Leayn Flaherty; Renuka Iyer; John Gibbs; Boris Kuvshinoff; Gregory Wilding; Graham Warren; Gary Y Yang
Journal: J Gastrointest Oncol Date: 2012-12

6. Image-guided intensity-modulated radiotherapy for pancreatic carcinoma.

Authors: Martin Fuss; Adrian Wong; Clifton D Fuller; Bill J Salter; Cristina Fuss; Charles R Thomas
Journal: Gastrointest Cancer Res Date: 2007-01

Review 7. Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer.

Authors: Annarosa Arcangeli; Olivia Crociani; Lapo Bencini
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2014-02-03 Impact factor: 6.237